ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2872

Long Noncoding RNA Nron Regulates The Cytoplasmic-Nuclear Shuttling and Activity Of NFAT5 In Rheumatoid Arthritis Synovial Fibroblast

Kunihiko Umekita1, Michelle Trenkmann1, Christoph Kolling2, Beat A. Michel3, Renate E. Gay4, Steffen Gay1 and Mojca Frank Bertoncelj5, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Schultess Clinic, Zurich, Switzerland, 3Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, 5Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epigenetics, inflammation and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Pathogenetic Pathways

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Long noncoding RNAs (lncRNAs) are critical regulators of gene expression and of major biological processes, such as cell migration, proliferation and invasion. The lncRNA NRON, Noncoding Repressor of Nuclear factor of activated T cells (NFAT), was recently shown to repress the cytoplasmic-nuclear translocation and function of NFAT1-4 transcription factors. It is unknown, however, whether NRON can regulate the function of NFAT5, which was reported to influence the migration and proliferation of rheumatoid arthritis synovial fibroblasts (RASF).

Here we investigated the expression and regulation of NRON in RASF and analyzed its role in regulating the function of NFAT5. 

Methods:

The expression of NFAT5 protein in RA (n=3) and osteoarthritis (OA) (n=3) synovial tissues was analyzed by immunohistochemistry. RASF were transfected with siRNA targeting NRON (n=4) or NFAT5 (n=4) using Lipofectamine 2000. Gene expression in SF was measured by quantitative real-time PCR with normalization to GAPDH or β2-microglobulin. Successful silencing of NFAT5 in SF was confirmed by Western blotting using α-tubulin for normalization. The secretion of IL-6 was measured by ELISA. Immunofluorescence microscopy was used to investigate the cytoplasmic- nuclear trafficking of NFAT5 in RASF transfected with siNRON or stimulated with TNFα (10ng/ml). The formation of stress fibers in SF after silencing of NRON was assessed by phalloidin staining. Migration of SF was analyzed by scratch assay.

Results:

The expression of NFAT5 protein was increased in RA compared to OA synovial tissues. The constitutive levels of NFAT5 mRNA (mean dCt±SD: 5.1±0.5 vs 5.8±0.7, p= 0.01) and NRON (mean dCt±SD: 11.7±0.7 vs 13.0±0.5, p= 0.01) were significantly up regulated in RASF (n=15) compared with OASF (n=11). The expression of NRON significantly correlated with the levels of NFAT5 mRNA in RASF (R=0.71, p=0.003). Furthermore, silencing of NFAT5 in RASF resulted in a down regulation of NRON (x-fold±SD: 0.57±0.3, p=0.07, n=4), indicating that NFAT5 regulates the expression of NRON in RASF. Stimulation of RASF with TNFα (2h) also significantly decreased the expression of NRON (by 26.9±25%, p= 0.02, n=7). Importantly, down regulation of NRON in RASF after silencing or TNFα stimulation was accompanied by the translocation of NFAT5 protein from the cytoplasm to the nucleus and by up regulation of NFAT5 target genes, including IL-6 (x-fold±SD: 3.0±2.2, p=0.03, n=4) and MMP-13 (x-fold±SD: 4.7±2.0, p= 0.03) mRNAs. The levels of IL-6 protein also significantly increased by silencing of NRON compared to control (mean±S.D: 1676±479 vs 2433±504 pg/mL, p= 0.007, n=5). Furthermore, silencing of NFAT5 resulted in a significant down regulation of MMP-13 mRNA (x-fold±SD: 0.58±0.2, p=0.02, n=4). The formation of stress fibers (n=3) and the migratory abilities of RASF (n=4) were increased after silencing of NRON.

Conclusion:

Our data indicate that the lncRNA NRON regulates gene expression profiles, stress fiber formation and migration of RASF in a NFAT5-dependent manner and can therefore significantly contribute to the pathogenic characteristics of activated synovial fibroblasts in RA.


Disclosure:

K. Umekita,

Japan Rheumatism Fundation,

2,

IAR, EURO-TEAM, IMI BTCure,

2;

M. Trenkmann,

EURO-TEAM, IMI BTCure, IAR Epalinges, KFSP USZ,

2;

C. Kolling,
None;

B. A. Michel,
None;

R. E. Gay,

EURO-TEAM, IMI BTCure, IAR Epalinges,

2;

S. Gay,

EURO-TEAM, IMI BTCure, IAR Epalinges, ,

2;

M. Frank Bertoncelj,

IAR, EURO-TEAM, IMI BTCure,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-noncoding-rna-nron-regulates-the-cytoplasmic-nuclear-shuttling-and-activity-of-nfat5-in-rheumatoid-arthritis-synovial-fibroblast/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology